John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 35,000 shares at $34.32 ($1.2M) on 2022-12-13, disclosed to the SEC on 2022-12-15.
Open-market sale of $1.2M VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |